tiprankstipranks
Trending News
More News >
Viatris (IT:1VTRS)
:1VTRS
Italy Market
Advertisement

Viatris (1VTRS) Earnings Dates, Call Summary & Reports

Compare
1 Followers

Earnings Data

Report Date
Mar 02, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.46
Last Year’s EPS
0.47
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strong commercial performance in certain segments and strategic advancements in R&D, offset by challenges related to the Indore facility and specific market declines. The company is actively addressing these issues and making progress in its strategic initiatives.
Company Guidance
During the Viatris Q3 2025 earnings call, several key metrics and guidance were discussed. The company reported a 1% operational revenue growth, excluding the impact of the Indore facility, and increased their full-year guidance for total revenues, adjusted EBITDA, and adjusted EPS. They emphasized their robust free cash flow generation, which amounted to $658 million for the quarter, enabling them to return over $920 million to shareholders year-to-date, including $500 million in share repurchases. The company has set a target to return over $1 billion in capital to shareholders for the year. Viatris is also actively advancing its pipeline, with significant progress noted in their fast-acting meloxicam and low-dose estrogen patch, among others. They are conducting an enterprise-wide strategic review to identify cost savings opportunities and plan to share detailed results, including quantification of net cost savings and reinvestment opportunities, in the first quarter of 2026.
Strong Commercial Performance
The quarter's commercial performance was strong across the portfolio, particularly in Europe, emerging markets, and Greater China, with 1% operational revenue growth excluding Indore.
R&D Advancements
Progress was made in the R&D pipeline, including advancements in the fast-acting meloxicam, sotagliflozin filings in multiple markets, and Phase III enrollment for selatogrel and cenerimod.
Capital Return to Shareholders
Over $920 million returned to shareholders year-to-date, including $500 million in share repurchases, on track to return over $1 billion in capital for the year.
Positive New Product Revenue Momentum
New product revenues in Europe grew by 5%, driven by new products in key markets like France and Italy.

Viatris (IT:1VTRS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IT:1VTRS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 02, 2026
2025 (Q4)
0.46 / -
0.467
Nov 06, 2025
2025 (Q3)
0.54 / 0.58
0.648-10.67% (-0.07)
Aug 07, 2025
2025 (Q2)
0.48 / 0.54
0.596-10.14% (-0.06)
May 08, 2025
2025 (Q1)
0.43 / 0.43
0.579-25.37% (-0.15)
Feb 27, 2025
2024 (Q4)
0.49 / 0.47
0.536-12.90% (-0.07)
Nov 07, 2024
2024 (Q3)
0.59 / 0.65
0.682-4.94% (-0.03)
Aug 08, 2024
2024 (Q2)
0.59 / 0.60
0.65-8.24% (-0.05)
May 09, 2024
2024 (Q1)
0.58 / 0.58
0.669-13.44% (-0.09)
Feb 28, 2024
2023 (Q4)
0.56 / 0.54
0.583-8.01% (-0.05)
Nov 07, 2023
2023 (Q3)
0.64 / 0.68
0.755-9.62% (-0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IT:1VTRS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
€9.13€8.79-3.70%
Aug 07, 2025
€7.57€7.56-0.13%
May 08, 2025
€7.43€8.00+7.72%
Feb 27, 2025
€10.57€8.79-16.84%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Viatris (IT:1VTRS) report earnings?
Viatris (IT:1VTRS) is schdueled to report earning on Mar 02, 2026, Before Open (Confirmed).
    What is Viatris (IT:1VTRS) earnings time?
    Viatris (IT:1VTRS) earnings time is at Mar 02, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Viatris stock?
          The P/E ratio of Viatris is N/A.
            What is IT:1VTRS EPS forecast?
            IT:1VTRS EPS forecast for the fiscal quarter 2025 (Q4) is 0.46.

              Viatris (IT:1VTRS) Earnings News

              VTRS Earnings: Viatris’ Revenue Declines in Q4;  Boosts Buybacks
              Premium
              Market News
              VTRS Earnings: Viatris’ Revenue Declines in Q4; Boosts Buybacks
              2y ago
              Here’s Why Viatris (NASDAQ:VTRS) Shares Soared 13% Recently
              Premium
              Market News
              Here’s Why Viatris (NASDAQ:VTRS) Shares Soared 13% Recently
              3y ago
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis